The All Ordinaries Index (ASX: XAO) is up a healthy 1.09% in afternoon trade, boosted by today's unexpectedly muted inflation print.
And these three ASX All Ordinaries stocks are doing more than their share of the lifting.
Here's why investors have sent them soaring more than 10% today.
Three ASX All Ordinaries shares setting the bar high
Up first, we have Latin Resources Ltd (ASX: LRS).
The ASX All Ordinaries lithium miner is up 21.2% at the time of writing, trading for 30 cents per share.
Investors are bidding up the Latin Resources share price after the company provided a promising update detailing spodumene discoveries at its Salinas Lithium Project, located in Brazil.
Latin Resources said its latest exploration results confirmed "the presence of a 'district scale' lithium corridor" within its tenements.
Operations vice president Americas Tony Greenaway said the latest drilling results validated the lithium explorer's "regional interpretation of a large, mineralised pegmatite system".
He added the system could potentially extend "up to 26 kilometres to the southwest of our flagship Colina Deposit".
Next up, we have ASX All Ordinaries cannabis stock, Vitura Health Ltd (ASX: VIT).
Vitura Health creates medicinal cannabis products and digital health solutions. And shares are up 14.7% in afternoon trade today to 55 cents.
There's no fresh market-sensitive news out from Vitura. But the cannabis stock has been on a tear over the past 12 months, up almost 120%.
Which brings us to the third ASX All Ordinaries share shooting the lights out today, biotechnology company Imugene Ltd (ASX: IMU).
Imugene is focused on cancer immunotherapy, working to treat and eliminate tumours. And the Imugene share price is up a stellar 13.1% to 9.5 cents per share today.
Like Vitura, there's no new price-sensitive news out from Imugene. But with the biotech company's shares down 31% in 2023, today's big lift will come as welcome news to shareholders.
